Inmode
Inmode
INMD
NASDAQ
18.37
USD
-0.49%
About
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health.
The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market.
These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 935.1K |
| Three Month Average Volume | 26.2M |
| High Low | |
| Fifty-Two Week High | 39.54 USD |
| Fifty-Two Week Low | 15.41 USD |
| Fifty-Two Week High Date | 01 Sep 2023 |
| Fifty-Two Week Low Date | 28 Aug 2024 |
| Price and Volume | |
| Current Price | 16.71 USD |
| Beta | 2 |
| Relative Price Change | |
| Four Week Relative Price Change | -7.83% |
| Thirteen Week Relative Price Change | -18.39% |
| Twenty-Six Week Relative Price Change | -33.72% |
| Fifty-Two Week Relative Price Change | -65.89% |
| Year-to-Date Relative Price Change | -36.55% |
| Price Change | |
| One Day Price Change | 4.44% |
| Thirteen Week Price Change | -12.65% |
| Twenty-Six Week Price Change | -27.13% |
| Five Day Price Change | 2.83% |
| Fifty-Two Week Price Change | -57.25% |
| Year-to-Date Price Change | -24.87% |
| Month-to-Date Price Change | -7.78% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 9.37543 USD |
| Book Value Per Share (Most Recent Quarter) | 9.08862 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 9.37543 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 9.08862 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 1.56483 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 5.72458 USD |
| Revenue Per Share (Trailing Twelve Months) | 4.84171 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 2.30263 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 1.73277 USD |
| Normalized (Last Fiscal Year) | 2.30263 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 2.36933 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.77786 USD |
| Including Extraordinary Items (Last Fiscal Year) | 2.30263 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 1.73277 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 8.83047 USD |
| Cash Per Share (Most Recent Quarter) | 8.82347 USD |
| Cash Flow Per Share (Last Fiscal Year) | 2.30987 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 1.74077 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 1.95653 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 40 |
| Cash Flow Revenue (Trailing Twelve Months) | 40 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 39.51% |
| Pretax Margin (Last Fiscal Year) | 44.16% |
| Pretax Margin (5 Year) | 43.50% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 83.60% |
| Gross Margin (Trailing Twelve Months) | 82.27% |
| Gross Margin (5 Year) | 84.46% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 39.76% |
| Operating Margin (Trailing Twelve Months) | 32.18% |
| Operating Margin (5 Year) | 41.61% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 40.22% |
| Net Profit Margin (Trailing Twelve Months) | 35.81% |
| Net Profit Margin (5 Year) | 39.65% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 69.15% |
| Tangible Book Value (5 Year) | 78.65% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 36.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -36.47% |
| Revenue Growth (3 Year) | 37.49% |
| Revenue Change (Trailing Twelve Months) | -16.16% |
| Revenue Per Share Growth | 29.57% |
| Revenue Growth (5 Year) | 33.65% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 13.10% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -57.38% |
| EPS Change (Trailing Twelve Months) | -18.93% |
| EPS Growth (3 Year) | 45.75% |
| EPS Growth (5 Year) | 37.22% |
| EBITDA | |
| EBITDA (5 Year) | 44.03% |
| EBITDA (5 Year Interim) | 25.29% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | 12.49% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 2 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 7 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 8 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -729,208,000 |
| Net Debt (Last Fiscal Year) | -741,605,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 3 |
| Price to Sales (Trailing Twelve Months) | 3 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 10 |
| PE Normalized (Last Fiscal Year) | 7 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 10 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 46 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 10 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 10 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 2 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 0.00% |
| Payout Ratio (Trailing Twelve Months) | 0.00% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 12 |
| Quick Ratio (Most Recent Quarter) | 8 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 3 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 4 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 13 |
| Current Ratio (Most Recent Quarter) | 9 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 176.1M |
| Free Cash Flow (Trailing Twelve Months) | 168.4M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 26.25% |
| Return on Assets (Trailing Twelve Months) | 18.72% |
| Return on Assets (5 Year) | 31.32% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 29.50% |
| Return on Equity (Trailing Twelve Months) | 21.05% |
| Return on Equity (5 Year) | 36.38% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 29.07% |
| Return on Investment (Trailing Twelve Months) | 20.79% |
| Return on Investment (5 Year) | 35.64% |